NKT Therapeutics Garners $4,000,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ddb2b94e-8fb5-489c-835c-3e5422bd2dc4&Preview=1 - Date
8/25/2010 - Company Name
NKT Therapeutics - Mailing Address
1000 Winter Street Waltham, MA 02451 - Company Description
NKT Therapeutics, Inc. (the Company) is a biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. NKT cells are a rare but central component of the human immune system which plays a pivotal role in human health and disease. - Website
http://www.nktrx.com - Transaction Type
Venture Equity - Transaction Amount
$4,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
